Navigation Links
ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
Date:9/30/2008

OR AKIVA, Israel, September 30 /PRNewswire-FirstCall/ -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged with research, development, manufacturing and marketing of heterologous tissue covered stents, announced that its second heterologous tissue covered stent - AneuGraft(R) received CE Mark approval.

AneuGraft(R) is a stent 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. It is intended for situations in tortuous vessels.

"AneuGraft(R) Pericardium Covered Stent is especially suitable for patients with tortuous vessels where other covered stents may not be adequate for use due to limitations resulting from tortuous anatomy" says Efri Argaman ITGI Medical CEO.

The CE Mark approval for AneuGraft(R) will enable ITGI Medical to provide a wide range of coronary interventional solutions for all those situations that need to set a barrier between the vessel wall and its lumen, despite the anatomical limitations. The AneuGraft(R) is mounted on a delivery system specially designed to improve the stent navigability in tortuous vessels.

About AneuGraft(R)

AneuGraft (R) is a unique stent, second in a series of heterologous tissue covered stents, designed to set a barrier between the blood vessel wall and its lumen. AneuGraft (R) PCS is indicated for treatment of bypass stenosis, aneurysms and for emergency situations such as perforations in tortuous vessels.

About ITGI Medical

ITGI medical is engaged with research and development, manufacturing and marketing of heterologous tissue covered stents. Over and Under(R) is the first among series of heterologous covered stents designed to treat coronary lesions and aneurysms. The world stent market has a value estimation of 6.4 Billion USD, of which 37% are generated in the USA.

Danna Moran

VP Marketing

ITGI Medical Ltd.

P: +972-72-2200335

F: +972-72-2200346

M: +97
'/>"/>

SOURCE ITGI Medical LTD
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...stCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopharmac...gnovelpainmanagementtherapies,announcedtodaythatAn...cheduledtopresentatthe21stAnnualPiperJaffrayHealth...kPalaceHotelinNewYork,NewYork. ,, Mr.DiTonnoand...abletorespondtoquestionsduringthepresentationsandt...
(Date:11/24/2009)...atientswithadvanced-stage,orrecurrentendometrialca...l/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the"...endocrinetherapyandoncology,todayannouncedpositive...icpeptideconjugate,AEZS-108(formerlyAN-152),inpati...rsonalizedhealthcareapproach,thestudyselectedpatie...
(Date:11/24/2009)...FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )today...airman,willpresentatthe21stAnnualPiperJaffrayHealt...09at10:00a.m.ET. ,, Toaccesstheliveandsubsequen...orRelationssectionofGenomicHealth,swebsiteat http:...bsiteatleast15minutespriortothebeginningoftheprese...
(Date:11/24/2009)...-CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTIC)mana...CareConference.TheconferencewillbeheldDecember1-2,...onTuesday,December1at11:00a.m.EasternTimeinHolmes1...lbeavailableat www.celltherapeutics.com ,anditwill...ayHealthCareConference,NewYorkPalaceHotel,Holmes1(...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
... Eiger BioPharmaceuticals, Inc.,a start-up biotec...nounced,that it has raised $7.1 million in a Serie...o Ventures. The two firms were instrumental in the...eam and are represented on the board of,directors ...gelman,respectively. The funding will advance the...
...-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NAS...ceutical and medical device company, today announc...d conference call. The call will take place at 10:..., , , Dial information for the earnings call o...ows:, North America (toll-free): (800) 291-9234...
... An investor group in Trinity,Biotech plc (Nasdaq:...er of,diagnostic products, has petitioned the Offi...ilitate compliance with key company law provisions...ders and prospective shareholders. , The petit...directors,Peter Coyne of Allied Irish Bank, and Dr...
Other Biology Technology:Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round 2
(Date:11/23/2009)...tudy by University of Alabama at Birmingham (UAB) ...o-existing medical conditions (co-morbidity) do no...rican-Americans compared to Caucasians who also ha.... 23 in Cancer , a journal of the American Cancer...BMI and co-morbidity are independent predictors of...
(Date:11/23/2009)...fornia biomedical engineer and cardiologist Tzung ...linicians distinguish cardiac emergencies requirin...le with drugs and lifestyle change. , Angiograms...ies feeding the heart, offer an inside view of the..., often revealing deposits of a dangerous fatty su...
(Date:11/23/2009)... , , , , , , , ..., Dr Andrew Marshall, from the Environment Depa...scovery of Kinyongia magomberae and his wider wo...r more information. , , , , ... , , , , , , A new species of ch...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 1Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 2Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 3Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 4Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 1Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 2The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 1The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 2
...ersity of Delaware have uncovered a hidden weapon ...e United States uses to silently and efficiently b...hragmites australis, or common reed, believed to h...n acid so toxic that the substance literally disin...ighboring plants, thus toppling the competition. ,...
...ome analysis of a tiny green alga has uncovered hu...carbon dioxide capture and generation of biomass. ...are those that encode the structure and function o...ynthetic apparatus, the chloroplast, which is resp...The genome also provides a glimpse back through ti...
...chnology infrastructure for researching and develo...ave the industry hundreds of millions of dollars a...red by the National Institute of Standards and Tec...or NIST, the studys authors found that over the la...s shifted from small-molecule chemicals to large-m...
Other Biology News:UD plant biologists uncover top wetland plant's hidden weapon 2UD plant biologists uncover top wetland plant's hidden weapon 3Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3Biopharmaceutical infrastructure key to lower drug development costs 2
Anti-4-hydroxy-2-hexenal Monoclonal Antibody, Unconjugated from Cosmo Bio Co., Ltd.
Anti-Human VEGFR-2 / KDR Antibody, Unconjugated from Cell Sciences
Rabbit Anti-Human Tankyrase 2 (TNKL (TNKS2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
...olved in translation initiation. PHAS-II is highes...E, the mRNA cap-binding protein, and inhibit trans...horylation in the appropriate site(s) promotes dis...F-4E to bind to eIF-4G (p220), thereby increasing ...
Biology Products: